EpCAM antibody Biotinylated (Extracellular domain)
Product Includes
Application Dilution
Immunofluorescence 1:200–1:400
CTC Reported in the literature, not verified in house
Storage
100mM Tris Glycine, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative
Specificity / Sensitivity
Source / Immunogen
This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]
| Title | |
|---|---|
| No data. | |
Reviews
IR218-3-Bio anti-EpCAM Biotinylated antibody WB image
Anti-EpCAM Biotinylated antibody - at 1/1500 dilution
Lysates at 40 μg per lane. This blot was produced using a 10% SDS-PAGE. Nitrocellulose membrane was then blocked for an hour before being incubated with IR218-3-Bio overnight at 4°C and developed using Streptavidin-HRP.
IR218-3-Bio anti-EpCAM Biotinylated antibody IF image
Immunofluorescence analysis of paraffin embedded human tissue labeling EpCAM with IR218-3-Bio and developed using Streptavidin, Alexa Fluor™ 488 conjugate.